iNOS is a mediator of increased arterial intimal thickening induced by passive cigarette smoke exposure in mice  by Anazawa, Takeo et al.
JACC March 19,2003 ABSTRACTS - Vascular Disease, Hypertension, and Prevention 303A 
vasodilatation (P8.03) and resulted in higher plasma t-PA antigen and activity concen- 
trations during bradykinin Infusion (11.3+0.8 vs 6.6~0.5 ng/mL and 16.5t3.9 vs 6.6k2.0 
IU/mL at peak bradykinin dose: PcO.002) and a doubling of estimated net t-PA release 
(PcO.05). Conclusion: Intra-arterial TNF-a causes an acute local vascular inflammation 
associated with a substantial and sustained increase in local t-PA and IL-6 release. TNF- 
a also impairs endothelium-dependent vasomotion and augments acute endothelial t-PA 
release. These findings indicate that TNF-a has potentially adverse and beneficial effects 
on endothelial and vascular function. 
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856-4 iNOS Is a Mediator of Increased Arterial lntimal 
Thickening Induced by Passive Cigarette Smoke 
Exposure in Mica 
Takeo Anazawa, Paul C. Dimayuga, Hongyan Li, Previn de Silva, Juliana Yano, Kuang- 
Yuh Chyu, Prediman K. Shah, Bojan Cercek, Cedars-Sinai Medical Center, Los Angeles, 
CA 
Background: Active and paswe smoking was associated with increased intimal/medial 
thickening in the Atherosclerosis Risk In Communities study, but molecular mechanisms 
contributing to this risk are incompletely understood. We evaluated the effect of passive 
smoke on arterial response to injury, and the potential role of iNOS gene in smoking 
induced effects on the arterial wall using iNOS -/- mice. 
Methods: Vascular injury was induced by placing a cuff around the right carotid attery. 
Wild type mice and iNOS -I- mice of the same background were exposed to passive 
smoke (1 agarettelday) or filtered room air. Expression of iNOS and PCNA in the arterial 
wall 3 days after injury was determined by immunostaining. Nitrate and nitrite (NOx) level 
3 days after injury was measured by Griess reaction. lntimal thickening was measured 21 
days after injury. 
Results: iNOS expression in wld type mice exposed to passive smoke increased com- 
pared to mice exposed to room air, and was not detected in iNOS -I- mice. lntimal thick- 
ening in iNOS-i- mice exposed to passive smoke was profoundly reduced compared to 
wld type mice exposed to passive smoke (Table). 
Medial areas were similar in all groups of mice. 
Conclusion: Our results suggest that iNOS expression is a key mediator in the aug- 
mented response to injury in mice exposed to cigarette smoke. iNOS may mediate vaso- 
occlusive effects of exposure to cigarette smoke. 
Table: 
Groups 
PCNA 
positive 
nuclei 
Wild-type + Wild-type + iNOS -/- mice + iNOS -I- mice + 
Room air Passive smoke Room air Passive smoke 
6.1 i2.7 ND 4.0 24.0 (Il=3) 
(Il=5) 
15.725.2 ” 
(rl=5) 
NOx level 22.3~ 7.3 39.1+ 12.8” 14.3 26.6” 12.5 + 6.6 (n=6) 
(lw (n=6) (n=5) @=6) 
lntimal Area 9.2 -+ 7.5 23.3+ 12.9’” 5.5i4.7” 2.1 + 1.6 (n=5) 
(m&x 16) (n=6) (ll=5) (ll=5) 
#p<O.O5 vs iNOS -I- +Passive smoke, ‘~~0.05 vs Wild-type+Room air, @I ~~0.05 vs 
Wild-type+Passive smoke; ANOVA 
3:oo p.m. 
856-5 Cardiovascular Effects of the Endogenous Nitric Oxide 
Synthase Inhibitor Asymmetric Dimathylarginina 
(ADMA) and Evidence for ADMA Metabolism in Humans 
In Vivo 
Vinod Achan Michael Broadhead. Mohammed Malaki. James Leiper. Raymond -3 
MacAllister. Patrick Valiance, University College London, London, Untted Kingdom 
BACKGROUND: Plasma levels of an endogenous NOS inhibitor, asymmetric dimethy- 
latginine (ADMA), are elevated in chronic renal failure, hypertension, and atherosclero- 
sis. ADMA levels are also significantly raised in patients with chronic heart failure (CHF) 
and in animals with CHF induced by coronary artery ligation or rapid pacing. Despite 
these obsewations the cardiovascular effects of a systemic increase in ADMA have not 
been studied in humans. METHODS: In a randomised, double-blind, placebo-controlled 
study using healthy male volunteers, we compared the effects of intravenous low dose 
ADMA and placebo on heart rate, blood pressure, cardiac output and systemic vascular 
resistance (SVR) at rest and during exercise. We also tested the hypothesis that ADMA 
IS metabolised extensively in humans in viva by a family of dimethylarginine dimethylami- 
nohydrolase (DDAH) enzymes. RESULTS: Low dose ADMA reduced heart rate by a 
maximum of 9.2+1.4% from 58.9k2.0 beats per min (PcO.OOl), and reduced cardiac out- 
put by a maximum of 14&1.2% from 4.4+0.3 Umin (PcO.001). ADMA also increased 
mean blood pressure by a maximum of 6.0*1.2% from E&6&3.4 mm Hg (PcO.CQS), and 
increased SVR by a maximum of 23.7t2.1% from 1639.0*91.6 dynes.s.cm-5 (P<O.OOl). 
Handgrip exercise Increased cardiac output in control subjects by a maximum of 
96.8+23.3%. In contrast, those subjects given ADMA increased their cardiac output by 
35.3+10.6% during exercise, representing a significant reduction in the cardiac response 
to exercise (PcO.05). DDAHs metabolise ADMA to citrulline and dimethylamine (DMA). 
Urinary DMA:Cr ratios significantly increased from 1.26kO.32 to 2.73kO.59 following 
ADMA injection (PcO.01). We estimate from this that humans generate approximately 
300umol of ADMA per day, of which approximately 250umol is metabolised by DDAHs. 
CONCLUSIONS: This study defines the cardiovascular effects of a systemic increase in 
ADMA in humans. These are similar to changes seen in diseases associated with ADMA 
accumulation, suggesting that ADMA could directly contribute to their pathogenesis. 
Finally, our data also indicate that ADMA is metabolised by DDAHs extensively in 
humans in viva. 
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856-6 Levels of Nitrotyrosina, an Inflammatory Marker 
Generated by Nitric Oxide Derived Oxidants, Is 
Associated With Risk of Coronary Artery Disease 
Mehdi H. Shishehbor, Ronnier J. Aviles, Marie-L”& Brennan, Xiaoming Fu, Marc S. 
Penn. Dennis L. Sprecher, Noyan Gokce, John F. Keaney, Jr., Joseph A. Vita, Stanley L. 
Hazen, The Cleveland Clinic Foundation, Cleveland, OH, Boston University School of 
Medicine, Boston, MA 
Background: Formation of nitric oxide (.NO)-derived oxidants may selve as a mechanism 
linking inflammation to development of atherosclerosis. Nitrotyrosine. a specific marker 
for protein modification by .NO-derived oxidants. is enriched in human atherosclerotic 
lesions and LDL recovered from human atheroma. Whether systemic levels of nitroty- 
rosine predict coronary artery disease (CAD) is not known. 
Methods: Serum nitrotyrosine levels in 262 consecutive patients at a major metropolitan 
medical center were determined by mass spectrometry and correlated with the preva- 
lence of CAD. 
Results: The median nitrotyrosine content of plasma proteins was significantly higher in 
the CAD group (9.13 umoVmol vs. 5.66 umol/mol, P c 0.001). Subjects in the upper quar- 
tile of nitrotyrosine levels had higher risk of CAD (unadjusted odds ratio, 4.06; 95% confi- 
dence interval, 1.94 to 8.50; P < 0.001). After adjusting for Framingham risk factors and 
high sensitive C-reactive protein, upper quartiles of nitrotyrosine remained predictive for 
CAD risk (odds ratio, 3.01; 95% confidence interval, 1.26 to 7.07; P < 0.001). 
Conclusion: Elevated levels of nitrotyrosine, a specific protein modification produced by 
.NO-derived oxidants and which is linked to CAD pathogenesis, serves as a significant 
and independent predictor of CAD risk. These results support a potential role for .NO- 
derived oxidants as an inflammatory mediator in CAD and may have important implica- 
tions for atherosclerosis diagnosis and risk assessment, 
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857-l Incidence and Characteristics of Ruptured Plaque in 
Femoro-Poplitaal Arteries 
Yoichiro Honaq Ali Hassan, Krishnankutty Sudhir. Daniel Adelman, Yasuhiro Honda, 
Paul G. Yock, Peter J. Fitzgerald, Stanford University, Stanford, CA, Pharmacyclics Inc., 
Sunnyvale, CA 
Background: Numerous studies have reported the characteristics of atherosclerotic 
lesions with plaque rupture in coronary arteries. However the incidence and characteris- 
tics of plaque rupture in the peripheral circulation have not been well studied. 
Methods: Ninety-seven lesions in 40 patients scheduled for elective angloplasty in either 
the femoral or popliteal arteries were enrolled. IVUS was performed before intervention. 
Lesion inclusion criteria were: (1) segmental, (2) proximal reference % plaque area < 
50%, (3) degree of calcified arc < 90”. Discontinuity of luminal sulfate with a cavity within 
the plaque mass was defined as plaque rupture. Lumen area, vessel area, degree of cal- 
cified arc. plaque eccentricity index (El) and remodeling index (RI: lesion I proximal refer- 
ence vessel area) were measured. 
Results: Plaque rupture was observed in 42 lesions (43%). When lesions with and with- 
out plaque rupture were compared, lumen area, degree of calcified arc and El were iden- 
tical (6.9k3.7 vs.6.9+5.2m& 22+25 vs.25+31’, 0.74*0.16 vs.O.73*0.16, NS). However, 
vessel area and RI were significantly higher in lesion with plaque rupture (30.1*6.0 
vs.26.0*6.9mm? p=O.OOl. 1.09+0.19 vs.O.98+0.16, p=O.OOS). The distribution of remod- 
